Lukatch Heath 4
4 · Vaxcyte, Inc. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Lukatch Heath
Director
Transactions
- Exercise/Conversion
Common Stock
2024-01-29$16.00/sh+4,000$64,000→ 9,625 total - Sale
Common Stock
2024-01-29$67.50/sh−4,000$270,000→ 5,625 total - Exercise/Conversion
Stock Option (right to buy)
2024-01-29−4,000→ 11,000 totalExercise: $16.00Exp: 2030-06-10→ Common Stock (4,000 underlying)
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2023.
- [F2]Fully vested and exercisable.